Predictive circulating biomarkers of the response to anti-PD-1 immunotherapy in advanced HER2 negative breast cancer.

Clin Transl Med · 2025 · PMC11859116 · PMID 40000397

Europe PMC DOI

hedged sentence

0.1350

closest p · 2.7× alpha

0.1350

boldest claim

The sentences

did not reach statistical significancep = .135not close (p > 0.1)

We paid particular attention to the expression of PD‐L1, which tended to be higher in non‐responders, although this discrepancy did not reach statistical significance ( p = .135; Figure S4B ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.